Vergne L - Search Results

Year	Number of Results
1962	1
1991	1
1996	1
1999	1
2000	3
2001	2
2002	6
2003	3
2004	1
2005	2
2006	5
2007	3
2008	3
2009	3
2011	2
2013	1
2014	1
2015	1
2016	1
2024	0

1

Characterization of HIV-1 genotypes and antiretroviral drug-resistance mutations among patients in Burkina Faso.

Kagone TS, Hien H, Meda N, Diagbouga PS, Sawadogo A, Drabo J, Peeters M, Vergne L, Delaporte E, De Souza C, Gbeassor M, Simpore J. Kagone TS, et al. Among authors: vergne l. Pak J Biol Sci. 2011 Mar 15;14(6):392-8. doi: 10.3923/pjbs.2011.392.398. Pak J Biol Sci. 2011. PMID: 21902063

2

Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine.

Laurent C, Kouanfack C, Koulla-Shiro S, Njoume M, Nkene YM, Ciaffi L, Brulet C, Peytavin G, Vergne L, Calmy A, Mpoudi-Ngolé E, Delaporte E. Laurent C, et al. Among authors: vergne l. AIDS. 2007 Mar 30;21(6):768-71. doi: 10.1097/QAD.0b013e328045c4d7. AIDS. 2007. PMID: 17413701 Clinical Trial.

3

Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus.

Nagot N, Ouédraogo A, Foulongne V, Konaté I, Weiss HA, Vergne L, Defer MC, Djagbaré D, Sanon A, Andonaba JB, Becquart P, Segondy M, Vallo R, Sawadogo A, Van de Perre P, Mayaud P; ANRS 1285 Study Group. Nagot N, et al. Among authors: vergne l. N Engl J Med. 2007 Feb 22;356(8):790-9. doi: 10.1056/NEJMoa062607. N Engl J Med. 2007. PMID: 17314338 Free article. Clinical Trial.

4

The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study.

Laurent C, Diakhaté N, Gueye NF, Touré MA, Sow PS, Faye MA, Gueye M, Lanièce I, Touré Kane C, Liégeois F, Vergne L, Mboup S, Badiane S, Ndoye I, Delaporte E. Laurent C, et al. Among authors: vergne l. AIDS. 2002 Jul 5;16(10):1363-70. doi: 10.1097/00002030-200207050-00008. AIDS. 2002. PMID: 12131213 Clinical Trial.

5

Comparison of antibody responses after vaccination with two inactivated rabies vaccines.

Minke JM, Bouvet J, Cliquet F, Wasniewski M, Guiot AL, Lemaitre L, Cariou C, Cozette V, Vergne L, Guigal PM. Minke JM, et al. Among authors: vergne l. Vet Microbiol. 2009 Jan 13;133(3):283-6. doi: 10.1016/j.vetmic.2008.06.024. Epub 2008 Jul 5. Vet Microbiol. 2009. PMID: 18757142 Clinical Trial.

6

Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries.

Aghokeng AF, Vergne L, Mpoudi-Ngole E, Mbangue M, Deoudje N, Mokondji E, Nambei WS, Peyou-Ndi MM, Moka JJ, Delaporte E, Peeters M. Aghokeng AF, et al. Among authors: vergne l. Antivir Ther. 2009;14(3):401-11. doi: 10.1177/135965350901400313. Antivir Ther. 2009. PMID: 19474474

7

Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries.

Vergne L, Malonga-Mouellet G, Mistoul I, Mavoungou R, Mansaray H, Peeters M, Delaporte E. Vergne L, et al. J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):165-8. doi: 10.1097/00042560-200202010-00009. J Acquir Immune Defic Syndr. 2002. PMID: 11832686

8

Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Côte d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study.

Ayouba A, Lien TT, Nouhin J, Vergne L, Aghokeng AF, Ngo-Giang-Huong N, Diop H, Kane CT, Valéa D, Rouet F, Joulia-Ekaza D, Toni TD, Nerrienet E, Ngole EM, Delaporte E, Costagliola D, Peeters M, Chaix ML. Ayouba A, et al. Among authors: vergne l. AIDS Res Hum Retroviruses. 2009 Nov;25(11):1193-6. doi: 10.1089/aid.2009.0142. AIDS Res Hum Retroviruses. 2009. PMID: 19886834

9

Genotypic drug resistance interpretation algorithms display high levels of discordance when applied to non-B strains from HIV-1 naive and treated patients.

Vergne L, Snoeck J, Aghokeng A, Maes B, Valea D, Delaporte E, Vandamme AM, Peeters M, Van Laethem K. Vergne L, et al. FEMS Immunol Med Microbiol. 2006 Feb;46(1):53-62. doi: 10.1111/j.1574-695X.2005.00011.x. FEMS Immunol Med Microbiol. 2006. PMID: 16420597 Free article.

10

Herpes Simplex Virus Type-2 Cervicovaginal Shedding Among Women Living With HIV-1 and Receiving Antiretroviral Therapy in Burkina Faso: An 8-Year Longitudinal Study.

Low AJ, Nagot N, Weiss HA, Konate I, Kania D, Segondy M, Meda N, van de Perre P, Mayaud P; Yerelon Study Group. Low AJ, et al. J Infect Dis. 2016 Mar 1;213(5):731-7. doi: 10.1093/infdis/jiv495. Epub 2015 Oct 15. J Infect Dis. 2016. PMID: 26475931 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Results by year